Influenza Vaccine and Egg Allergy
All persons aged ≥6 months with egg allergy should receive influenza vaccine, and any influenza vaccine (egg-based or non-egg-based) that is otherwise appropriate for the recipient's age and health status can be used, regardless of the severity of their previous egg allergy reaction 1, 2.
Key Recommendation
The most recent ACIP guidelines (2025-26 season) are unequivocal: egg allergy alone necessitates no additional safety measures for influenza vaccination beyond those recommended for any recipient of any vaccine, regardless of severity of previous reaction to egg 1, 2. This represents a significant departure from older protocols that required skin testing or graded dosing.
Clinical Approach
For Patients with Egg Allergy (Any Severity):
- Administer the full dose of any age-appropriate influenza vaccine in a single administration
- No vaccine skin testing required
- No graded dosing required
- No extended observation period specifically for egg allergy
- No referral to an allergist is necessary for egg allergy alone
Standard Safety Measures (Apply to ALL Vaccine Recipients):
- Administer in settings where personnel and equipment for rapid recognition and treatment of acute hypersensitivity reactions are available
- All vaccination providers should be familiar with their office emergency plan and certified in cardiopulmonary resuscitation
- Consider observing patients for 15 minutes after administration (seated or supine) to decrease risk of injury from syncope 2
Evidence Supporting This Approach
The guideline recommendations are based on compelling safety data. Reviews of studies administering egg-based influenza vaccines to persons with egg allergy have noted no cases of anaphylaxis or serious hypersensitivity reactions 2. Research has documented approximately 4,315 egg-allergic patients safely receiving 4,872 total doses, including 656 patients with severe egg allergy (including anaphylaxis to egg) who safely received 740 doses 3.
Importantly, severe allergic reactions have been reported after administration of egg-free recombinant influenza vaccine (RIV) to egg-allergic persons 2, 4. This highlights that observed reactions after egg-based vaccines are likely caused by substances other than egg proteins, further supporting that egg allergy itself is not the relevant risk factor.
Critical Distinction: Egg Allergy vs. Vaccine Allergy
While egg allergy is not a contraindication, a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any influenza vaccine remains a contraindication 5. This is the key distinction that matters clinically.
Vaccine Options
Most influenza vaccines contain trace amounts of egg protein (generally ≤1 μg/0.5mL dose) 2. However, egg-free options are available:
- Flublok (RIV3): recombinant vaccine, approved for ages ≥9 years (expanded from ≥18 years in 2025) 1
- Flucelvax (ccIIV3): cell culture-based vaccine, approved for ages ≥6 months 2
However, there is no need to preferentially use egg-free vaccines in egg-allergic patients - any age-appropriate vaccine can be used 1, 2.
Common Pitfalls to Avoid
- Do not withhold influenza vaccine from egg-allergic patients
- Do not perform vaccine skin testing for egg allergy
- Do not use graded dosing protocols for egg allergy
- Do not require extended observation periods beyond the standard 15-minute recommendation for all vaccines
- Do not refer to allergist solely for egg allergy and influenza vaccination
The only scenario requiring allergist evaluation is if a patient has had a previous severe allergic reaction to an influenza vaccine itself, as this requires careful evaluation to determine the causative agent and guide future immunization 2.